4.4 Article

BODY MASS INDEX, NOT DYSLIPIDEMIA, IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Energy metabolism in amyotrophic lateral sclerosis

Luc Dupuis et al.

LANCET NEUROLOGY (2011)

Article Clinical Neurology

Hypermetabolism in ALS patients: an early and persistent phenomenon

C. Bouteloup et al.

JOURNAL OF NEUROLOGY (2009)

Article Multidisciplinary Sciences

Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups

Jeban Ganesalingam et al.

PLOS ONE (2009)

Article Clinical Neurology

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

L. Dupuis et al.

NEUROLOGY (2008)

Article Biochemistry & Molecular Biology

Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis

Anissa Fergani et al.

JOURNAL OF LIPID RESEARCH (2007)

Article Clinical Neurology

Trial of celecoxib in amyotrophic lateral sclerosis

Merit E. Cudkowicz et al.

ANNALS OF NEUROLOGY (2006)

Article Clinical Neurology

Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters

Jean-Claude Desport et al.

NEURODEGENERATIVE DISEASES (2005)

Article Clinical Neurology

Premorbid weight, body mass, and varsity athletics in ALS

N Scarmeas et al.

NEUROLOGY (2002)

Article Clinical Neurology

El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis

BR Brooks et al.

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)